1.
Is Home Blood Pressure Monitoring Useful in the Management of Patients With Resistant Hypertension?
by Muxfeldt, Elizabeth S
American journal of hypertension, 2015-02, Vol.28 (2), p.190-199
2.
Prognosis of White-Coat and Masked Hypertension International Database of Home Blood Pressure in Relation to Cardiovascular Outcome
by Stergiou, George S
Hypertension (Dallas, Tex. 1979), 2014-04, Vol.63 (4), p.675-682
3.
Prognostic significance of visit-to-visit variability, maximum systolic blood pressure, and episodic hypertension
by Rothwell, Peter M, Prof
The Lancet (British edition), 2010, Vol.375 (9718), p.895-905
4.
Effect of Spironolactone on Blood Pressure in Subjects With Resistant Hypertension
by Chapman, Neil
Hypertension (Dallas, Tex. 1979), 2007-04, Vol.49 (4), p.839-845
5.
Prognosis of Masked and White Coat Uncontrolled Hypertension Detected by Ambulatory Blood Pressure Monitoring in Elderly Treated Hypertensive Patients
by Pierdomenico, Sante D
American journal of hypertension, 2017-11-01, Vol.30 (11), p.1106-1111
6.
Ambulatory Blood Pressure Patterns in Children With Chronic Kidney Disease
by Samuels, Joshua
Hypertension (Dallas, Tex. 1979), 2012-07, Vol.60 (1), p.43-50
7.
Atenolol in hypertension: is it a wise choice?
by Carlberg, Bo
The Lancet (British edition), 2004, Vol.364 (9446), p.1684-1689
8.
Should β blockers remain first choice in the treatment of primary hypertension? A meta-analysis
by Lindholm, Lars Hjalmar
The Lancet (British edition), 2005, Vol.366 (9496), p.1545-1553
9.
Reduction in Albuminuria Translates to Reduction in Cardiovascular Events in Hypertensive Patients: Losartan Intervention for Endpoint Reduction in Hypertension Study
by Ibsen, Hans
Hypertension (Dallas, Tex. 1979), 2005-02, Vol.45 (2), p.198-202
10.
Prevention of cardiovascular events with an antihypertensive regimen of amlodipine adding perindopril as required versus atenolol adding bendroflumethiazide as required, in the Ang...
by Dahlöf, Björn
The Lancet (British edition), 2005-09-10, Vol.366 (9489), p.895-906
11.
Role of blood pressure and other variables in the differential cardiovascular event rates noted in the Anglo-Scandinavian Cardiac Outcomes Trial-Blood Pressure Lowering Arm (ASCOT-...
by Poulter, Neil R
The Lancet (British edition), 2005-09-10, Vol.366 (9489), p.907-913
12.
Hypertension Treatment and Control in Five European Countries, Canada, and the United States
by Wolf-Maier, Katharina
Hypertension (Dallas, Tex. 1979), 2004-01, Vol.43 (1), p.10-17
13.
Effect of Baseline Cognitive Function and Antihypertensive Treatment on Cognitive and Cardiovascular Outcomes: Study on COgnition and Prognosis in the Elderly (SCOPE)
by Skoog, Ingmar
American journal of hypertension, 2005, Vol.18 (8), p.1052-1059
14.
Molecular Characterization of Reactive Oxygen Species in Systemic and Pulmonary Hypertension
by Zuo, Li
American journal of hypertension, 2014-05, Vol.27 (5), p.643-650
15.
Left Atrial Size and Risk of Major Cardiovascular Events During Antihypertensive Treatment: Losartan Intervention for Endpoint Reduction in Hypertension Trial
by Gerdts, Eva
Hypertension (Dallas, Tex. 1979), 2007-02, Vol.49 (2), p.311-316
16.
Azilsartan Is Associated With Increased Circulating Angiotensin-(1–7) Levels and Reduced Renovascular 20-HETE Levels
by Carroll, Mairéad A
American journal of hypertension, 2015-05, Vol.28 (5), p.664-671
17.
In-Treatment Resolution or Absence of Electrocardiographic Left Ventricular Hypertrophy Is Associated With Decreased Incidence of New-Onset Diabetes Mellitus in Hypertensive Patien...
by Okin, Peter M
Hypertension (Dallas, Tex. 1979), 2007-11, Vol.50 (5), p.984-990
18.
Hospitalizations for New Heart Failure Among Subjects With Diabetes Mellitus in the RENAAL and LIFE Studies
by Carr, Albert A
The American journal of cardiology, 2005, Vol.96 (11), p.1530-1536
19.
Prevalence, awareness, treatment, and control of hypertension in China: data from 1·7 million adults in a population-based screening study (China PEACE Million Persons Project)
by Lu, Jiapeng
The Lancet (British edition), 2017-12-09, Vol.390 (10112), p.2549-2558
20.
Gut Dysbiosis Is Linked to Hypertension
by Yang, Tao
Hypertension (Dallas, Tex. 1979), 2015-06, Vol.65 (6), p.1331-1340
